Journal of Antimicrobial Chemotherapy

Other Departments

David Reeves, David Speller, and Bob Spencer

Preface
J. Antimicrob. Chemother. 1989 23: iii; doi:10.1093/jac/23.suppl_C.iii [PDF] [Request Permissions]  

Articles

Get checked abstract G. Franceschi, E. Perrone, M. Alpegiani, A. Bedeschi, C. Battistini, F. Zarini, and C. Della Bruna

Synthesis and antimicrobial spectrum of FCE 22101 and its orally available ester FCE 22891
J. Antimicrob. Chemother. 1989 23: 1-6; doi:10.1093/jac/23.suppl_C.1 [Abstract] [PDF] [Request Permissions]  

Get checked abstract R. Wise and R. C. Ballard

Review of the in-vitro evaluation of FCE 22101
J. Antimicrob. Chemother. 1989 23: 7-16; doi:10.1093/jac/23.suppl_C.7 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Arthur L. Barry, Ronald N. Jones, and Clyde Thornsberry

In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests
J. Antimicrob. Chemother. 1989 23: 17-30; doi:10.1093/jac/23.suppl_C.17 [Abstract] [PDF] [Request Permissions]  

Get checked abstract K. Dornbusch, G. Kronvall, E. Göransson, and E. Mörtsell

In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of β-lactamases
J. Antimicrob. Chemother. 1989 23: 31-41; doi:10.1093/jac/23.suppl_C.31 [Abstract] [PDF] [Request Permissions]  

Get checked abstract K. Dornbusch, G. Kronvall, E. Göransson, and E. Mörtsell

Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates
J. Antimicrob. Chemother. 1989 23: 43-52; doi:10.1093/jac/23.suppl_C.43 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Daryl J. Hoban

In-vitro activity of a new penem FCE 22101
J. Antimicrob. Chemother. 1989 23: 53-57; doi:10.1093/jac/23.suppl_C.53 [Abstract] [PDF] [Request Permissions]  

Get checked abstract L. J. V. Piddock, E. A. Traynor, and R. Wise

Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins
J. Antimicrob. Chemother. 1989 23: 59-64; doi:10.1093/jac/23.suppl_C.59 [Abstract] [PDF] [Request Permissions]  

Get checked abstract J. P. Maskell, Tu Tang, S. Asad, and J. D. Williams

Comparative inhibitory and bactericidal activities of FCE 22101 against Gram-positive cocci and anaerobes in vitro
J. Antimicrob. Chemother. 1989 23: 65-74; doi:10.1093/jac/23.suppl_C.65 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Daniela Jabes and Alexander Tomasz

Lytic and bactericidal activity of FCE 22101
J. Antimicrob. Chemother. 1989 23: 75-83; doi:10.1093/jac/23.suppl_C.75 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Youjun Yang and David M. Livermore

Interactions of FCE 22101 with Class I β-lactamases
J. Antimicrob. Chemother. 1989 23: 85-94; doi:10.1093/jac/23.suppl_C.85 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Nai-Xun Chin and Harold C. Neu

In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents
J. Antimicrob. Chemother. 1989 23: 95-101; doi:10.1093/jac/23.suppl_C.95 [Abstract] [PDF] [Request Permissions]  

Get checked abstract A. A. Said and D. M. Livermore

In-vitro interactions of FCE 22101 with aminoglycosides against Gram-negative rods
J. Antimicrob. Chemother. 1989 23: 103-108; doi:10.1093/jac/23.suppl_C.103 [Abstract] [PDF] [Request Permissions]  

Get checked abstract K. Dornbusch, C. Henning, and E. Lindén

In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis
J. Antimicrob. Chemother. 1989 23: 109-117; doi:10.1093/jac/23.suppl_C.109 [Abstract] [PDF] [Request Permissions]  

Get checked abstract C. Della Bruna, D. Jabes, R. Rossi, G. Younes, and P. Castellani

FCE 22101 and FCE 22891: in-vitro antibacterial activity at concentrations simulating human plasma levels following intravenous, intramuscular and oral administration
J. Antimicrob. Chemother. 1989 23: 119-128; doi:10.1093/jac/23.suppl_C.119 [Abstract] [PDF] [Request Permissions]  

Get checked abstract M. Brughera, G. Scampini, M. L. Ferrari, A. Nava, and G. Mazué

Toxicological profile of FCE 22101 and its orally available ester FCE 22891
J. Antimicrob. Chemother. 1989 23: 129-135; doi:10.1093/jac/23.suppl_C.129 [Abstract] [PDF] [Request Permissions]  

Get checked abstract C. E. Nord and G. Lahnborg

Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats
J. Antimicrob. Chemother. 1989 23: 137-141; doi:10.1093/jac/23.suppl_C.137 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Ronald J. Dworkin, Jay H. Tureen, Steven L. Kennedy, Meena Sachdeva, and Merle A. Sande

Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae
J. Antimicrob. Chemother. 1989 23: 143-148; doi:10.1093/jac/23.suppl_C.143 [Abstract] [PDF] [Request Permissions]  

Get checked abstract R. Rossi, P. Castellani, G. Younes, and C. Della Bruna

Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice
J. Antimicrob. Chemother. 1989 23: 149-155; doi:10.1093/jac/23.suppl_C.149 [Abstract] [PDF] [Request Permissions]  

Get checked abstract P. Castellani, G. Meinardi, and C. Della Bruna

Activity of FCE 22101 and other β-lactam antibiotics against experimental genital infections in the rat and mouse
J. Antimicrob. Chemother. 1989 23: 157-163; doi:10.1093/jac/23.suppl_C.157 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Margherita Strolin Benedetti, Giancarlo Goldaniga, Lilli Montesanti, Rosangela Battaglia, and Gianpiero Vicario

Disposition of ¹⁴C-labelled FCE 22101 in animals
J. Antimicrob. Chemother. 1989 23: 165-171; doi:10.1093/jac/23.suppl_C.165 [Abstract] [PDF] [Request Permissions]  

Get checked abstract Margherita Strolin Benedetti, Rosangela Battaglia, Gianpiero Vicario, and Romeo Roncucci

Urinary metabolites of ¹⁴C-labelled FCE 22101 in animals
J. Antimicrob. Chemother. 1989 23: 173-177; doi:10.1093/jac/23.suppl_C.173 [Abstract] [PDF] [Request Permissions]  

Get checked abstract A. M. Lovering, L. O. White, D. A. Lewis, A. P. MacGowan, K. R. Routh, D. M. Pickin, and D. S. Reeves

Pharmacokinetics of FCE 22101 in man following different modes of administration
J. Antimicrob. Chemother. 1989 23: 179-195; doi:10.1093/jac/23.suppl_C.179 [Abstract] [PDF] [Request Permissions]  

Get checked abstract D. Sassella, G. Cassinelli, R. Corigli, P. Dewland, V. Hutt, H. Lode, and R. C. Ballard

Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intake
J. Antimicrob. Chemother. 1989 23: 197-203; doi:10.1093/jac/23.suppl_C.197 [Abstract] [PDF] [Request Permissions]  

Index

Index
J. Antimicrob. Chemother. 1989 23: 205-208; doi:10.1093/jac/23.suppl_C.205 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.